Related News
Home 禄 Business 禄 Manufacturing
UK drug maker builds largest factory in Jiangsu
By Ding Yining |
January 4, 2012, Wednesday
|
Online Edition
Online Edition
ASTRAZENECA today started the construction of a US$230 million plant in neighboring Jiangsu Province as it joins other multinational drug companies to ride on the growth of China and other emerging markets.
The new manufacturing facility -- the largest of AstraZeneca, London-based biopharmaceutical company -- is expected to be completed at the end of 2013.
It will produce both drugs developed by AstraZeneca and generic branded pharmaceutical products.
Last November, AstraZeneca took over private-owned Guangdong Beikang Pharmaceutical to diversify its product line for generic drugs.
AstraZeneca also operates a US$134 million manufacturing and supply site in Wuxi New District in Jiangsu Province, which has been in operation since 2001.
The new manufacturing facility -- the largest of AstraZeneca, London-based biopharmaceutical company -- is expected to be completed at the end of 2013.
It will produce both drugs developed by AstraZeneca and generic branded pharmaceutical products.
Last November, AstraZeneca took over private-owned Guangdong Beikang Pharmaceutical to diversify its product line for generic drugs.
AstraZeneca also operates a US$134 million manufacturing and supply site in Wuxi New District in Jiangsu Province, which has been in operation since 2001.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
